Cancer pavilion in New Brunswick will focus on clinical trials

The Cancer Institute of New Jersey is partnering with Rutgers University and RWJBarnabas Health, an underwriter of NJTV News, to launch a cancer pavilion, a place where research and treatment will happen under one roof.

Fifty thousand people are diagnosed with cancer in New Jersey every year. A surprising fact shared Monday: New Jerseyans have less access to clinical trials than in other states, and that’s something they hope to correct at the pavilion.

“It’s a long history of having not made the investment to recruit what’s necessary to do medical research,” said RWJ Barnabas President and CEO Barry Ostrowsky. “So the anomaly of having a wealthy state, 9 million people, with the home of the pharmaceutical industry, but not have medical research, we think will be cured sometime over the course of the next five to 10 years.”

A billion dollars will be invested over the next 20 years to recruit investigators and researchers who will run clinical trials. The groundbreaking on the pavilion is slated for next spring.